Dor Pélvica Crônica: uso de Cannabis medicinal e aspectos legais

The treatment of chronic pelvic pain (CPP) is challenging due to the tendency for pain to progressively worsen and the high rate of symptom recurrence. Given its physical and social repercussions, it is essential to invest in the study of alternative therapies. This study aimed to investigate the scientific evidence for the medicinal use of cannabis in PCD and its legal framework, through a narrative search. The studies show promising partial results in pain control, but are still limited in their conclusions; while in the legal sphere there is a disparity between recommendations from representative institutions and the absence of a specific provision in the law regulating medicinal use. There needs to be a synergistic progression between legal debate with regulatory clarity and an improvement in the quality of scientific evidence supporting its use. Keywords: Pelvic Pain; Medical Marijuana; Cannabidiol; ANVISA; SUS

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-11-13
DOI
https://doi.org/10.5281/zenodo.14154682
Primary Topic
Cannabis and Cannabinoid Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dor Pélvica Crônica: uso de Cannabis medicinal e aspectos legais

Zenodo (CERN European Organization for Nuclear Research)
Cannabis and Cannabinoid Research
article

Dor Pélvica Crônica: uso de Cannabis medicinal e aspectos legais

article en

Abstract

The treatment of chronic pelvic pain (CPP) is challenging due to the tendency for pain to progressively worsen and the high rate of symptom recurrence. Given its physical and social repercussions, it is essential to invest in the study of alternative therapies. This study aimed to investigate the scientific evidence for the medicinal use of cannabis in PCD and its legal framework, through a narrative search. The studies show promising partial results in pain control, but are still limited in their conclusions; while in the legal sphere there is a disparity between recommendations from representative institutions and the absence of a specific provision in the law regulating medicinal use. There needs to be a synergistic progression between legal debate with regulatory clarity and an improvement in the quality of scientific evidence supporting its use. Keywords: Pelvic Pain; Medical Marijuana; Cannabidiol; ANVISA; SUS

Zenodo (CERN European Organization for Nuclear Research)
Universidade Santa Cecília (BR)
Good health and well-being
Openalex Percentile: Top 50%
Cannabis and Cannabinoid Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.